_id
6919f00c3c536f8df231857a
Ticker
VLG.LSE
Name
Venture Life Group PLC
Exchange
LSE
Address
12 The Courtyard, Bracknell, United Kingdom, RG12 2XB
Country
UK
Sector
Consumer Defensive
Industry
Household & Personal Products
Currency
GBX
Website
https://www.venture-life.com
Description
Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms related to rosacea; Bioscalin for the cosmetic treatment and prevention of hair loss, hair thinning, and baldness; and skincare solutions under the brand Lubatti. In addition, the company offers women's healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ name. Further, it provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos; Glucogel for the treatment of hypoglycaemia. Additionally, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; and Baby Earol, an ear spray for babies under the Earol and EarolSwim brands. It also provides oncology support products, such as Pomi-T for the management of prostate-specific antigen levels in prostate cancer; Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis; and Xonrid, a hyaluronic acid-based topical gel, for the prevention and treatment of radiation-induced dermatitis. The company operates in Germany, the Netherlands, France, Sweden, Denmark, Lithuania, rest of Europe, the United States, Canada, Brazil, Ireland, and internationally. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
Last Close
655000
Volume
21401
Current Price
64.75
Change
1.1450381679389312
Last Updated
2025-12-30T11:43:42.837Z
Image
https://logo.clearbit.com/www.venture-life.com
Ipo Date
-
Market Cap
83112840
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
15388000
Cost Of Revenue
8749000
Gross Profit
6639000
Operating Expenses
8042000
Operating Income
-416000
Interest Expense
836000
Pretax Income
-2032000
Net Income
-1461000
Eps
-0.011424268924006288
Dividends Per Share
-
Shares Outstanding
126689823
Income Tax Expense
77000
EBITDA
1439000
Operating Margin
-2.703405250844814
Total Other Income Expense Net
-1616000
Cash
2009000
Short Term Investments
-
Receivables
9510000
Inventories
6222000
Total Current Assets
74252000
Property Plant Equipment
618000
Total Assets
124908000
Payables
6820000
Short Term Debt
1093000
Long Term Debt
21933000
Total Liabilities
49681000
Equity
75227000
Bs_currency_symbol
GBP
Depreciation
2015000
Change In Working Capital
415000
Cash From Operations
691000
Capital Expenditures
29000
Cash From Investing
-875000
Cash From Financing
-337000
Net Change In Cash
-3566000
Cf_currency_symbol
-
PE
-
PB
110.07478051431002
ROE
-1.942121844550494
ROA
-1.1696608704006148
FCF
662000
Fcf Percent
0.043020535482193915
Piotroski FScore
2
Health Score
26
Deep Value Investing Score
4.5
Defensive Investing Score
6.5
Dividend Investing Score
3
Economic Moat Investing Score
6.8
Garp Investing Score
5.5
Growth Investing Score
5
Momentum Investing Score
7.5
Net Net Investing Score
2.5
Quality Investing Score
4
Value Investing Score
3
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
15388000
Quarters > 0 > income Statement > cost Of Revenue
8749000
Quarters > 0 > income Statement > gross Profit
6639000
Quarters > 0 > income Statement > operating Expenses
8042000
Quarters > 0 > income Statement > operating Income
-416000
Quarters > 0 > income Statement > interest Expense
836000
Quarters > 0 > income Statement > pretax Income
-2032000
Quarters > 0 > income Statement > net Income
-1461000
Quarters > 0 > income Statement > eps
-0.011424268924006288
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
127885645
Quarters > 0 > income Statement > income Tax Expense
77000
Quarters > 0 > income Statement > EBITDA
1439000
Quarters > 0 > income Statement > operating Margin
-2.703405250844814
Quarters > 0 > income Statement > total Other Income Expense Net
-1616000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
2009000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
9510000
Quarters > 0 > balance Sheet > inventories
6222000
Quarters > 0 > balance Sheet > total Current Assets
74252000
Quarters > 0 > balance Sheet > property Plant Equipment
618000
Quarters > 0 > balance Sheet > total Assets
124908000
Quarters > 0 > balance Sheet > payables
6820000
Quarters > 0 > balance Sheet > short Term Debt
1093000
Quarters > 0 > balance Sheet > long Term Debt
21933000
Quarters > 0 > balance Sheet > total Liabilities
49681000
Quarters > 0 > balance Sheet > equity
75227000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-1461000
Quarters > 0 > cash Flow > depreciation
2015000
Quarters > 0 > cash Flow > change In Working Capital
415000
Quarters > 0 > cash Flow > cash From Operations
691000
Quarters > 0 > cash Flow > capital Expenditures
29000
Quarters > 0 > cash Flow > cash From Investing
-875000
Quarters > 0 > cash Flow > cash From Financing
-337000
Quarters > 0 > cash Flow > net Change In Cash
-3566000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.011424268924006288
Quarters > 0 > ratios > PB
110.07478051431002
Quarters > 0 > ratios > ROE
-1.942121844550494
Quarters > 0 > ratios > ROA
-1.1696608704006148
Quarters > 0 > ratios > FCF
662000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.043020535482193915
Quarters > 0 > health Score
26
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
3139000
Quarters > 1 > income Statement > cost Of Revenue
-105000
Quarters > 1 > income Statement > gross Profit
3244000
Quarters > 1 > income Statement > operating Expenses
1473000
Quarters > 1 > income Statement > operating Income
1771000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
1660000
Quarters > 1 > income Statement > net Income
1373000
Quarters > 1 > income Statement > eps
0.010834887589935189
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
126720281
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
9962000
Quarters > 1 > income Statement > operating Margin
56.419241796750555
Quarters > 1 > income Statement > total Other Income Expense Net
-111000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
3053000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
10832000
Quarters > 1 > balance Sheet > inventories
5075000
Quarters > 1 > balance Sheet > total Current Assets
71816000
Quarters > 1 > balance Sheet > property Plant Equipment
769000
Quarters > 1 > balance Sheet > total Assets
124487000
Quarters > 1 > balance Sheet > payables
2730000
Quarters > 1 > balance Sheet > short Term Debt
1660000
Quarters > 1 > balance Sheet > long Term Debt
21782000
Quarters > 1 > balance Sheet > total Liabilities
49076000
Quarters > 1 > balance Sheet > equity
75411000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-
Quarters > 1 > cash Flow > depreciation
7742000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-5575000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.010834887589935189
Quarters > 1 > ratios > PB
108.80558797456604
Quarters > 1 > ratios > ROE
1.8206892893609685
Quarters > 1 > ratios > ROA
1.1029264099865848
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
48
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
23454000
Quarters > 2 > income Statement > cost Of Revenue
14512000
Quarters > 2 > income Statement > gross Profit
8942000
Quarters > 2 > income Statement > operating Expenses
9198000
Quarters > 2 > income Statement > operating Income
-256000
Quarters > 2 > income Statement > interest Expense
936000
Quarters > 2 > income Statement > pretax Income
-1641000
Quarters > 2 > income Statement > net Income
-1687000
Quarters > 2 > income Statement > eps
-0.013332849968126427
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
126529587
Quarters > 2 > income Statement > income Tax Expense
46000
Quarters > 2 > income Statement > EBITDA
2660000
Quarters > 2 > income Statement > operating Margin
-1.0914982518973309
Quarters > 2 > income Statement > total Other Income Expense Net
-1385000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
5575000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
13214000
Quarters > 2 > balance Sheet > inventories
10571000
Quarters > 2 > balance Sheet > total Current Assets
29360000
Quarters > 2 > balance Sheet > property Plant Equipment
9781000
Quarters > 2 > balance Sheet > total Assets
114246000
Quarters > 2 > balance Sheet > payables
9562000
Quarters > 2 > balance Sheet > short Term Debt
3468000
Quarters > 2 > balance Sheet > long Term Debt
13796000
Quarters > 2 > balance Sheet > total Liabilities
39913000
Quarters > 2 > balance Sheet > equity
74333000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-1687000
Quarters > 2 > cash Flow > depreciation
3365000
Quarters > 2 > cash Flow > change In Working Capital
2350000
Quarters > 2 > cash Flow > cash From Operations
4760000
Quarters > 2 > cash Flow > capital Expenditures
312000
Quarters > 2 > cash Flow > cash From Investing
-934000
Quarters > 2 > cash Flow > cash From Financing
-3782000
Quarters > 2 > cash Flow > net Change In Cash
-47000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.013332849968126427
Quarters > 2 > ratios > PB
110.21741027874565
Quarters > 2 > ratios > ROE
-2.269516903663245
Quarters > 2 > ratios > ROA
-1.4766381317507835
Quarters > 2 > ratios > FCF
4448000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.18964782126716126
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
27956000
Quarters > 3 > income Statement > cost Of Revenue
16527000
Quarters > 3 > income Statement > gross Profit
11429000
Quarters > 3 > income Statement > operating Expenses
8523000
Quarters > 3 > income Statement > operating Income
2906000
Quarters > 3 > income Statement > interest Expense
465000
Quarters > 3 > income Statement > pretax Income
2456000
Quarters > 3 > income Statement > net Income
2429000
Quarters > 3 > income Statement > eps
0.01725486983537824
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
140771853
Quarters > 3 > income Statement > income Tax Expense
27000
Quarters > 3 > income Statement > EBITDA
5118000
Quarters > 3 > income Statement > operating Margin
10.394906281299185
Quarters > 3 > income Statement > total Other Income Expense Net
-450000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
5622000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
16205000
Quarters > 3 > balance Sheet > inventories
10332000
Quarters > 3 > balance Sheet > total Current Assets
32159000
Quarters > 3 > balance Sheet > property Plant Equipment
10194000
Quarters > 3 > balance Sheet > total Assets
119495000
Quarters > 3 > balance Sheet > payables
5796000
Quarters > 3 > balance Sheet > short Term Debt
20342000
Quarters > 3 > balance Sheet > long Term Debt
0
Quarters > 3 > balance Sheet > total Liabilities
43241000
Quarters > 3 > balance Sheet > equity
76254000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
2429000
Quarters > 3 > cash Flow > depreciation
3317000
Quarters > 3 > cash Flow > change In Working Capital
-853000
Quarters > 3 > cash Flow > cash From Operations
4524000
Quarters > 3 > cash Flow > capital Expenditures
578000
Quarters > 3 > cash Flow > cash From Investing
-1751000
Quarters > 3 > cash Flow > cash From Financing
-1134000
Quarters > 3 > cash Flow > net Change In Cash
1964000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.01725486983537824
Quarters > 3 > ratios > PB
119.53441762727202
Quarters > 3 > ratios > ROE
3.185406667191229
Quarters > 3 > ratios > ROA
2.032721034352902
Quarters > 3 > ratios > FCF
3946000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.14115037916726283
Quarters > 3 > health Score
56
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
26593000
Annuals > 0 > income Statement > cost Of Revenue
14407000
Annuals > 0 > income Statement > gross Profit
12186000
Annuals > 0 > income Statement > operating Expenses
10671000
Annuals > 0 > income Statement > operating Income
1515000
Annuals > 0 > income Statement > interest Expense
1496000
Annuals > 0 > income Statement > pretax Income
19000
Annuals > 0 > income Statement > net Income
-314000
Annuals > 0 > income Statement > eps
-0.002477898545695302
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
126720281
Annuals > 0 > income Statement > income Tax Expense
46000
Annuals > 0 > income Statement > EBITDA
4321000
Annuals > 0 > income Statement > operating Margin
5.696987929154289
Annuals > 0 > income Statement > total Other Income Expense Net
-1496000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
3053000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
10832000
Annuals > 0 > balance Sheet > inventories
5075000
Annuals > 0 > balance Sheet > total Current Assets
71816000
Annuals > 0 > balance Sheet > property Plant Equipment
769000
Annuals > 0 > balance Sheet > total Assets
124487000
Annuals > 0 > balance Sheet > payables
2730000
Annuals > 0 > balance Sheet > short Term Debt
1660000
Annuals > 0 > balance Sheet > long Term Debt
21782000
Annuals > 0 > balance Sheet > total Liabilities
49076000
Annuals > 0 > balance Sheet > equity
75411000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
19000
Annuals > 0 > cash Flow > depreciation
2806000
Annuals > 0 > cash Flow > change In Working Capital
-73000
Annuals > 0 > cash Flow > cash From Operations
8351000
Annuals > 0 > cash Flow > capital Expenditures
10000
Annuals > 0 > cash Flow > cash From Investing
-11294000
Annuals > 0 > cash Flow > cash From Financing
1779000
Annuals > 0 > cash Flow > net Change In Cash
-1303000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.002477898545695302
Annuals > 0 > ratios > PB
111.49422026428503
Annuals > 0 > ratios > ROE
-0.41638487753775977
Annuals > 0 > ratios > ROA
-0.25223517315061006
Annuals > 0 > ratios > FCF
8341000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.3136539690896101
Annuals > 0 > health Score
42
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
51410000
Annuals > 1 > income Statement > cost Of Revenue
31260000
Annuals > 1 > income Statement > gross Profit
20150000
Annuals > 1 > income Statement > operating Expenses
16861000
Annuals > 1 > income Statement > operating Income
3289000
Annuals > 1 > income Statement > interest Expense
2181000
Annuals > 1 > income Statement > pretax Income
1123000
Annuals > 1 > income Statement > net Income
921000
Annuals > 1 > income Statement > eps
0.006891905770960869
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
133635025
Annuals > 1 > income Statement > income Tax Expense
202000
Annuals > 1 > income Statement > EBITDA
9948000
Annuals > 1 > income Statement > operating Margin
6.397588017895352
Annuals > 1 > income Statement > total Other Income Expense Net
-2166000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
5622000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
16205000
Annuals > 1 > balance Sheet > inventories
10332000
Annuals > 1 > balance Sheet > total Current Assets
32159000
Annuals > 1 > balance Sheet > property Plant Equipment
10194000
Annuals > 1 > balance Sheet > total Assets
119495000
Annuals > 1 > balance Sheet > payables
5796000
Annuals > 1 > balance Sheet > short Term Debt
20342000
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
43241000
Annuals > 1 > balance Sheet > equity
76254000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
921000
Annuals > 1 > cash Flow > depreciation
6644000
Annuals > 1 > cash Flow > change In Working Capital
-1005000
Annuals > 1 > cash Flow > cash From Operations
8220000
Annuals > 1 > cash Flow > capital Expenditures
2407000
Annuals > 1 > cash Flow > cash From Investing
-5340000
Annuals > 1 > cash Flow > cash From Financing
-2806000
Annuals > 1 > cash Flow > net Change In Cash
-9000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
0.006891905770960869
Annuals > 1 > ratios > PB
116.27827928698821
Annuals > 1 > ratios > ROE
1.2078054921709025
Annuals > 1 > ratios > ROA
0.7707435457550524
Annuals > 1 > ratios > FCF
5813000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.11307138688971018
Annuals > 1 > health Score
49
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
43980000
Annuals > 2 > income Statement > cost Of Revenue
26315000
Annuals > 2 > income Statement > gross Profit
17665000
Annuals > 2 > income Statement > operating Expenses
15438000
Annuals > 2 > income Statement > operating Income
2227000
Annuals > 2 > income Statement > interest Expense
1522000
Annuals > 2 > income Statement > pretax Income
706000
Annuals > 2 > income Statement > net Income
520000
Annuals > 2 > income Statement > eps
0.003898228381892852
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
133393929
Annuals > 2 > income Statement > income Tax Expense
186000
Annuals > 2 > income Statement > EBITDA
7613000
Annuals > 2 > income Statement > operating Margin
5.063665302410186
Annuals > 2 > income Statement > total Other Income Expense Net
-1521000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
5631000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
16433000
Annuals > 2 > balance Sheet > inventories
11998000
Annuals > 2 > balance Sheet > total Current Assets
34062000
Annuals > 2 > balance Sheet > property Plant Equipment
10090000
Annuals > 2 > balance Sheet > total Assets
125289000
Annuals > 2 > balance Sheet > payables
7392000
Annuals > 2 > balance Sheet > short Term Debt
3867000
Annuals > 2 > balance Sheet > long Term Debt
19328000
Annuals > 2 > balance Sheet > total Liabilities
49630000
Annuals > 2 > balance Sheet > equity
75659000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
706000
Annuals > 2 > cash Flow > depreciation
5385000
Annuals > 2 > cash Flow > change In Working Capital
-1357000
Annuals > 2 > cash Flow > cash From Operations
5566000
Annuals > 2 > cash Flow > capital Expenditures
4206000
Annuals > 2 > cash Flow > cash From Investing
-11688000
Annuals > 2 > cash Flow > cash From Financing
6922000
Annuals > 2 > cash Flow > net Change In Cash
396000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
0.003898228381892852
Annuals > 2 > ratios > PB
116.98128694735588
Annuals > 2 > ratios > ROE
0.6872943073527273
Annuals > 2 > ratios > ROA
0.41504042653385376
Annuals > 2 > ratios > FCF
1360000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.030923146884947704
Annuals > 2 > health Score
41
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
32762000
Annuals > 3 > income Statement > cost Of Revenue
19804000
Annuals > 3 > income Statement > gross Profit
12958000
Annuals > 3 > income Statement > operating Expenses
11587000
Annuals > 3 > income Statement > operating Income
1371000
Annuals > 3 > income Statement > interest Expense
514000
Annuals > 3 > income Statement > pretax Income
946000
Annuals > 3 > income Statement > net Income
2402000
Annuals > 3 > income Statement > eps
0.017949571970336996
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
133819347
Annuals > 3 > income Statement > income Tax Expense
-1456000
Annuals > 3 > income Statement > EBITDA
5162000
Annuals > 3 > income Statement > operating Margin
4.184726207191258
Annuals > 3 > income Statement > total Other Income Expense Net
-425000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
5235000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
12212000
Annuals > 3 > balance Sheet > inventories
9019000
Annuals > 3 > balance Sheet > total Current Assets
26466000
Annuals > 3 > balance Sheet > property Plant Equipment
9737000
Annuals > 3 > balance Sheet > total Assets
103631000
Annuals > 3 > balance Sheet > payables
4308000
Annuals > 3 > balance Sheet > short Term Debt
1240000
Annuals > 3 > balance Sheet > long Term Debt
8483000
Annuals > 3 > balance Sheet > total Liabilities
30467000
Annuals > 3 > balance Sheet > equity
73164000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
946000
Annuals > 3 > cash Flow > depreciation
3702000
Annuals > 3 > cash Flow > change In Working Capital
-3179000
Annuals > 3 > cash Flow > cash From Operations
601000
Annuals > 3 > cash Flow > capital Expenditures
3262000
Annuals > 3 > cash Flow > cash From Investing
-39179000
Annuals > 3 > cash Flow > cash From Financing
1502000
Annuals > 3 > cash Flow > net Change In Cash
-36860000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
0.017949571970336996
Annuals > 3 > ratios > PB
121.3563183184353
Annuals > 3 > ratios > ROE
3.2830353725876114
Annuals > 3 > ratios > ROA
2.3178392565931043
Annuals > 3 > ratios > FCF
-2661000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
-0.08122214761003602
Annuals > 3 > health Score
48
Valuation > metrics > PE
-0.011424268924006288
Valuation > metrics > PB
110.07478051431002
Valuation > final Score
20
Valuation > verdict
3569.2% Overvalued
Profitability > metrics > ROE
-1.942121844550494
Profitability > metrics > ROA
-1.9676237677099608
Profitability > metrics > Net Margin
-0.09494411229529504
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.660414478844032
Risk > metrics > Interest Coverage
-0.49760765550239233
Risk > final Score
46
Risk > verdict
High
Liquidity > metrics > Current Ratio
9.383546063439908
Liquidity > metrics > Quick Ratio
8.59724503980791
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
20
Prev Valuations > 2
40
Prev Profitabilities > 0
39
Prev Profitabilities > 1
0
Prev Profitabilities > 2
42
Prev Risks > 0
49
Prev Risks > 1
47
Prev Risks > 2
73
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
73
Updated At
2026-01-20T23:04:47.052Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.0232
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0.0232
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-06-19
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
GBP
Earnings History > 1 > eps Actual
-0.01
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-09-30
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.01
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-12-31
Earnings History > 3 > report Date
2023-03-28
Earnings History > 3 > date
2022-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
0.01
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-09-29
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2022-03-24
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
0.02
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0.02
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-09-22
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-03-31
Earnings History > 7 > report Date
2021-04-05
Earnings History > 7 > date
2021-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
0.01
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-06-30
Earnings History > 8 > report Date
2020-09-24
Earnings History > 8 > date
2020-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
0.02
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0.02
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-03-31
Earnings History > 9 > report Date
2020-04-09
Earnings History > 9 > date
2020-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
0.01
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0.01
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-06-30
Earnings History > 10 > report Date
2019-09-19
Earnings History > 10 > date
2019-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-12-31
Earnings History > 11 > report Date
2019-03-21
Earnings History > 11 > date
2018-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
0.01
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.01
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-19
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
-0.01
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.01
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-12-31
Earnings History > 13 > report Date
2018-03-21
Earnings History > 13 > date
2017-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
0.01
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0.01
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-06-30
Earnings History > 14 > report Date
2017-09-19
Earnings History > 14 > date
2017-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-0.02
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-03-31
Earnings History > 15 > report Date
2017-05-02
Earnings History > 15 > date
2017-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
-0.01
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.01
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-06-30
Earnings History > 16 > report Date
2016-09-21
Earnings History > 16 > date
2016-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
-0.03
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.03
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2016-03-31
Earnings History > 17 > report Date
2016-05-09
Earnings History > 17 > date
2016-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
-0.02
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.02
Earnings History > 17 > surprise Percent
-
Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms related to rosacea; Bioscalin for the cosmetic treatment and prevention of hair loss, hair thinning, and baldness; and skincare solutions under the brand Lubatti. In addition, the company offers women's healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ name. Further, it provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos; Glucogel for the treatment of hypoglycaemia. Additionally, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; and Baby Earol, an ear spray for babies under the Earol and EarolSwim brands. It also provides oncology support products, such as Pomi-T for the management of prostate-specific antigen levels in prostate cancer; Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis; and Xonrid, a hyaluronic acid-based topical gel, for the prevention and treatment of radiation-induced dermatitis. The company operates in Germany, the Netherlands, France, Sweden, Denmark, Lithuania, rest of Europe, the United States, Canada, Brazil, Ireland, and internationally. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFrom Jamia to LSE with a Chevening: This year’s scholar shares what it truly takes beyond academics and good grades The Indian Express
Read more →UK Penny Stocks: 3 Promising Picks Below £80M Market Cap simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Venture Life Group PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
0.0232
EPS Estimate
0
EPS Difference
0.0232
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.